Bardet Biedl syndrome (BBS) is a rare inherited syndromic condition characterized by renal and extra-renal disorders. Renal defect, at either structural or functional level, is one of the cardinal clinical features, and is a major cause of morbidity. However, the pathogenic mechanism underlying its dysfunction remains largely unknown, and to date only symptomatic treatment with no specific therapy is available for these patients. Elucidating aberrant cellular and/or systemic processes that impact kidney function is therefore a prerequisite to develop targeted innovative therapeutic strategies for the BBS patients. Given the proven role of BBS proteins in the function of the primary cilium (PC) and considering the clinical overlapping of BBS with other ciliopathies, BBS is considered the result of disruption of ciliary activities. The present review aims at giving an updated overview of the spectrum of renal abnormalities in BBS patients according to the existing scientific literature, and discusses the possible role of intrinsic PC dysfunction into the pathogenesis of renal defects based on the most recent findings demonstrating a possible role of systemic factors in favoring the progression of renal disease.
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Introduction
Bardet Biedl syndrome is a rare genetic disorder with a wide spectrum of clinical manifestations. Retinal degeneration, polydactyly, obesity, learning impairment and renal abnormalities are considered the cardinal clinical features. Secondary features include syndactyly /brachydactyly, diabetes mellitus, heart disease, behavioral abnormalities, ataxia-poor coordination, anosmia and others ( Table 1 ). The clinical diagnosis was proposed by Beales and colleagues in the 1999 [1] , and it is based on the presence of four primary features or three primary features plus two secondary features. Clinical phenotype is highly variable, ranging from mild and sometimes underdiagnosed forms [2] , to severe phenotypes with multiple organ dysfunction. Rode-cone dystrophy is considered the most common finding, causing night blindness, loss of peripheral and progressively also central vision. Also polydactyly and obesity are very common. Obesity is considered of multifactorial origin; it has been associated with hyperleptinemia in either humans and experimental models due to hypotalamic resistance, but also defective adipogenesis has been described [3] . It is still unclear whether the nature of the genetic mutation may affect the severity of the phenotype. Possibly, truncating mutations rather than missense mutations may lead to milder phenotype [4] . Another possibility is the oligogenic feature of the BBS, where different genes may influence the severity of the phenotype. To date mutations in 21 different genes (BBS1-BBS20 and C8ORF37) have been identified [5] , and it is presumable that there are several other unmapped yet loci as fifteen percent of the overall BBS patients are not affected in the already discovered BBS genes. However, the evidence of a significant inter-and intrafamilial variability in BBS is difficult to explain considering the classic single-gene autosomal recessive model of inheritance. Some studies have suggested a triallelic inheritance [6] . Mutations in a second gene might modulate penetrance and expressivity of the first gene, and are highly likely responsible for clinical variability [7] ; however, the real pathogenic impact of heterozygote mutations remains elusive [8] .
Renal abnormalities in BBS
Renal disease is one of the cardinal features in BBS patients and is considered one of the main cause of mortality and morbidity [9] . The disease affects either kidney structure and function, according to the literature. Structural abnormalities include single or multiple parenchymal cysts, calyceal cysts, clubbing and blunting, fetal lobulations, renal hypoplasia, hyperechoic kidney, horseshoe kidney [1] . Often, malformations of the lower urinary tract have been described, including vesical-ureteric reflux, posterior urethral valve and persistent urogenital sinum [10] .
Renal dysfunctions range from impaired water handling with no significant electrolytes disturbances to the end stage renal disease [8] . The majority of reports show that more than half of the BBS patients exhibit normal eGFR [11, 12] . A recent retrospective study on a total of 350 BBS patients from the United Kingdom showed that the prevalence of CKD stage II-V were 42% and 31% in adult and children respectively and no difference between genders have been reported [4] . Patients with normal glomerular filtration rate (GFR) included either subjects with structural renal abnormalities and individuals with no any significant anomalies on kidney ultrasound. The study conducted on our Italian cohort of BBS patients evidenced that 65% of the tested patients did present an estimated glomerular filtration rate (eGFR) higher that 90 ml/min/1.73m 2 , corroborating the findings of the published English study [10] . General medical care of ESRD patients does not differ from normal population; in the literature, several reports describe patients with all modality of renal replacement therapy [13] [14] [15] . Urinalysis abnormalities are rare and proteinuria is an uncommon feature; generally it is present in patients with declined GFR; although our study revealed that the most severe proteinuric patients with normal GFR were the patients with morbid obesity, hypertension and diabetes [10, [16] [17] [18] . Little information on the incidence of kidney stones is present in the literature, and on the risk factors for lithogenesis in this setting [10,] . Electrolytes plasma levels are generally normal, and some studies indicate a higher incidence of incomplete distal renal tubule acidosis [20] , however a systemic chronic metabolic acidosis is a rare finding in the absence of renal insufficiency. A frequent finding in BBS patients with normal GFR is a defect in urine concentrating ability [21] . Harnett et al. in 1988 showed that BBS patients manifested a lower ability to maximally concentrate the urine after dehydration, in the absence of signs of plasmatic concentration [20; 22] . In addition, this study showed that urine osmolality did not increase significantly even after the injection of an analogue of Vasopressin, Desmopessin (dDAVP), indicating a renal origin of urine concentrating defect.
Our group has confirmed that hyposthenuria in BBS patients with normal GFR is dDAVPindependent, and has the kidney as the main determinant. In order to address the molecular basis underlying this defect, we assessed whether dDAVP-resistance is receptorial or postreceptorial. dDAVP is known to interact with V2R in either renal tubule and endothelial cells; upon receptor-ligand binding, Factor VIII and von Willebrand Factor (vWF) are released from endothelial cells to the plasma in a time dependent fashion. The analysis of the time course of Factor VIII and vWF after dDAVP infusion has been used to address the function of V2R in patients with X-linked diabetes insipidus, carrying V2R mutations [23] . Interestingly, the test showed a normal increased plasma levels of both molecules upon dDAVP infusion in BBS patients, suggesting an intact function of V2R, at least in endothelial cells [9] . Whether kidney specific V2R dysfunction occurs remains unexplored.
Then, we addressed whether downstream factors were implicated in the pathogenesis of hyposthenuria. Urine Aquaporin 2 (u-AQP2) excretion has been used as marker of its abundance on the apical membrane of principal collecting duct cells [24] . Interestingly, our study indicated that after long term water restriction, in hyposthenuric BBS patients u-AQP2 excretion was not different compared with healthy volunteers, indicating that the inability to reach the maximum urine osmolality in BBS patients is not the consequence of impaired AQP2 trafficking [10, 25] . However, after acute stimuli, namely acute water loading and dDAVP infusion, BBS patients showed a blunted response of u-AQP2 excretion.
The possible role of dysfunction in other nephron segments, and/or structural abnormalities that may affect the generation and maintenance of the medullar hypertonicity is currently under investigation. A putative role of a defective salt absorption along the thick ascending limb of Henle's loop (TAL) is suggested by the lower urinary levels of the TALspecific protein Uromodulin (UMOD) in hyposhtenuric BBS patients compared with non hyposthenuric BBS patients [10, 26] . In consistence with the inability to concentrate the urine due to renal impairment in fluid reabsorption, hypostenuric BBS patients have been shown to exhibit a reduced excretion fraction of uric acid [10, 27] , and increased levels of the plasma renin activity (PRA) [28] . The molecular basis of impaired water handling in BBS is still largely unknown; whether it is the result of intrinsic tubular reabsorption ability and /or structural defects at tubular and or vascular levels requires further investigations. Finally, the pathological contribution of impaired urine concentration and the predictive value of hyposthenuria on kidney disease progression is still an unanswered question in the BBS context [29] . A dual dysfunction of the medullary TAL and collecting duct has been described as secondary to selective autophagy defect in a mouse model deficient of prorenin receptor expression [30] ; whether mutant BBS subunits influence also the autophagy flux needs further studies.
Evidence supporting the role of local BBS dysfunction in the pathogenesis of kidney disease
Interestingly, most BBS genes contribute to the function of the PC. The BBS (1, 2, 4, 5, 7, 8, 9, and 18) proteins form a multiprotein complex called BBSome that functions as a trafficking machinery that delivers molecules from and to the cilium, while BBS17 exerts a negative regulation of its trafficking [31] . BBS6, BBS10 and BBS12 genes encode chaperoninlike proteins, localized in the basal body of the PC, that are believed to act as a molecular scaffold assisting the formation of the BBSome complex [32] . BBS13, BBS14, BBS15, and BBS16 encode basal body proteins and BBS3, BBS11, BBS19, BBS20, and NPHP1 have related functions [8] (Fig. 1) .
The PC is believed to play an important role in renal development and homeostasis [33] .
In the last decades, the discovery of the genetic bases of several renal cystic diseases and understanding the function of the corresponding gene products opened a new field of biological research, highlighting the role of the PC in physio-pathology [34] . In the subsequent years, a number of genetic loci associated with inherited renal and extra-renal disorders with similar phenotype have been mapped, and the translated proteins localized to the PC-basal body complex, opening the field of ciliopathies [35] . The autosomal dominant polycystic kidney disease (ADPKD), the autosomal recessive polycystic kidney disease are some examples of disruption of PC homeostasis and kidney dysfunction, sharing the onset of large fluid filled cysts with kidney enlargement. The Nephronophtisis, the Senior-Loken, Jeune, Meckel-Gruber and Oro-Facio-Digital type 1 syndromes are some other examples, where interstitial and glomerular fibrosis and tubular cysts have been found, besides extrarenal defects.
The link between PC dysfunction and renal abnormalities is object of intensive investigations.
Epithelial cells lining the nephron and the collecting ducts plus the parietal layer of Bowman's capsule express the PC [36] on podocytes proliferation and/or a repairing processes. In support of a possible biological role of the PC in glomerular function, recently Cong et al. have shown an association between a familial form of focal segmental glomerulosclerosis (FSGS) and a genetic mutation in the TTC21B (also known as THM1) gene, encoding a component of the intraflagellar transport complex IFT-A, indicating a possible role of this protein (and maybe the PC) besides tubular homeostasis [40] .
In renal epithelial cells, the PC is thought to serve as a mechanosensor. These cells exhibit a PC that extends from the apical membrane to the lumen for some microns. Flow-dependent PC deflections modulate Ca +2 signaling and several intracellular pathways regulating cell proliferation, gene transcription and cytoskeleton organization [41] and the expression/ activity of renal transporters activity [42, 43] .
In vitro studies, including renal epithelial cells, indicated that BBS silencing resulted in reduced number and size of PC [44] . We demonstrated that mouse-derived collecting duct cells lacking BBS1 and BBS10 failed to develop the PC, but showed normal polarization [28] .
Besides abnormalities in ciliogenesis, a series of aberrant biological functions have been described. Mice-derived primary renal cells lacking BBS4 and BBS6 genes show deficient movement, division and cytokinesis in the non-confluent state, in association with actin cytoskeleton disorganization [45] . In addition, BBS4-6 and 8 null cells showed overabundant focal adhesion (FAs). Previous findings showed that renal cells lacking BBS10 were unable to detect luminal vasopressin (ADH) and to increase AQP2 abundance at the apical level, suggesting a possible mechanism underlying a defective urine concentrating ability [44] . In addition, we have shown that in kidney cortical collecting duct-derived cells (MCD4), BBS10 silencing inhibited forskolin-induced AQP2 trafficking to the apical membrane, further confirming the role of this protein in AQP2 sorting [28] .
The exact function of the BBS proteins in the structure of the PC in vivo remains a question of debate. Adult Bbs2 knockout mice (Bbs2 -/-) develop renal cysts from renal tubules and glomeruli, while PC are detectable, even though in some cells show abnormal features [46] . Bbs4 null mice (Bbs4 -/-) recapitulate most of the clinical features of human BBS, including renal cysts and kidney dysfunction; however, they show the presence of the PC normally extending from apical surface of renal and tracheal epithelium [47] , suggesting that the associated BBS protein is not crucial for cilia assembly. Similarly, in Bbs6 -/-mice, renal epithelium develops normal cilia in size and number [48] .
Thus, the exact role of BBS proteins in PC assembly is still unclear; the absence of structural abnormalities in the PC in animal models of BBS do not exclude a role of those proteins in cilia signaling. Accordingly, animal models of ADPKD do not show gross structural abnormalities of the PC in the kidney [49] , but the fact that polycystins have a great impact on cilia function has been largely proven [50] .
While substantial research has carried out in the BBS field, the lack of detailed information on the possible role of aberrant signaling pathways in the pathogenesis of renal dysfunction in BBS has hindered the development of specific therapies. Some studies have demonstrated analogies with other genetic diseases leading to renal cysts or defective renal development. It has been shown that BBS proteins are involved in the WNT signaling, an essential signaling pathway in renal development [51] . BBS proteins are required for targeting planary cell polarity (PCP) components to the basal body [52] , raising the hypothesis of a role of BBS in PCP signaling. Recently we have identified the dysregulation of the PC in the glomerulocystic phenotype secondary to Dicer suppression [53] . Together with the impairment of the β-catenin/GSK3 β pathway this could be the underlying mechanism leading to the multiorgan cystic development in the Dicer syndrome.
Using three zebrafish models of BBS, with disruption of BBS4, 6 and 8, Tobin et al. showed that rapamycin and roscovitine reversed renal abnormalities at either morphological and functional level, suggesting a putative role of mTOR signaling pathway aberration in kidney dysfunction [54] . But further research is required to translate these approaches into the clinics as little data addressing these different issues in BBS patients are available in literature. In addition, the lack of longitudinal studies in BBS limits the possibility to address whether common or specific risk factors may contribute in worsening renal function over the years.
In the recent publication on the English cohort, it has been demonstrated that mutations in BBS2, 10 and 12 correlated with a most severe renal dysfunction compared with BBS1, confirming previous findings [4] . In addition, the study pointed that truncating mutations compared with missense mutations were associated with kidney dysfunction, suggesting that any BBS gene when strongly affected may lead to kidney disease. However, these findings do not answer the question whether local or systemic factors can impact renal function in the BBS. The evidence that structural abnormalities correlated with CKD-stage III-V suggests a strong contribution of defective kidney development into the pathogenesis of renal failure. Conversely, the analysis of the common risk factors for severe renal dysfunction revealed that obesity and BMI did not show a significant association with the GFR, while hypertension and albuminuria were more common in patients with advanced rather than initial stages of CKD. The study evidenced the association between some genetic mutations and renal phenotype; however, it does not provide strong conclusion on the role of common risk factors in kidney disease progression over the years.
Evidence supporting the role of systemic factors in kidney dysfunction in BBS
In general population, obesity, diabetes and hypertension are known risk factors of CKD [55, 56] .
Given the frequent coexistence of kidney dysfunction and systemic morbidities as obesity and hypertension in BBS patients, it is hard to dissect the role of local genetic factors vs systemic factors in initiating and accelerating the progression of renal failure.
A few recent studies have addressed the role of systemic factors in favoring kidney disease progression. Little information derives from human studies on this issue, and are mainly based on case reports. Dervisoglu et al. reported the case of two siblings affected by BBS that improved their renal function after two years of calorie and protein restricted diet [57] . The patients were aged 32-and 27-year-old, and presented a body mass index (BMI) of 40 and 39 kg/m 2 and a creatinine clearance of 41 and 24 ml/min respectively, in the presence of small and hyperechoic kidneys. After two years of follow up the BMI decreased to 29 and 26 kg/m 2 , while creatinine clearance increased to 44 and 32 respectively. The paper suggests that strict BMI control and protein intake may slow the progression of kidney disease.
Another interesting case report suggesting that metabolic factors may contribute to organ dysfunction in BBS was published in 2011 [58] . The authors reported the case of a 21-monthold girl, with polydactyly at the birth and obesity during the first infancy. Her prenatal kidney ultrasound showed enlarged kidneys at second trimester of gestation. Visual and behavioral impairment occurred, and the clinical diagnosis of BBS was later confirmed by the finding of a genetic mutation in BBS10 gene. The patient underwent a detailed biochemical testing, demonstrating multiple nutrient deficiency, including vitamin D, arginine, co-enzyme Q,10, vitamins B and folate. She showed high plasma levels of fatty acids and high urinary excretion of methylmaonate, suggesting a possible carnitine dysregulation. The patient underwent nutrient supplementation to correct the specific deficiency; strikingly, after 6 months the vision, the BMI and behavior improved significantly, and after three years she continued to develop normally, with no evidence of ophthalmological defects. Whether long term sequele of BBS, as renal impairment, may be affected somehow by nutritional supplementation remains to be elucidated.
In accordance with these clinical evidences, it has been shown that calorie restriction in two Bbs mouse models reduced the severity of kidney dysfunction [59] . In their study, Guo et al. demonstrated that obese hypertensive Bbs4 -/-mice exhibit inflammatory infiltration and renal cysts, and obese normotensive Bbs2 -/-show only inflammation. Whether these two genes exert a different impact in renal physio-pathology, or the presence/absence of hypertension has some role in cystogenesis is unclear. Interestingly, calorie restriction reduced the obesity phenotype and restored renal structural abnormalities in both models, implying a role of obesity in the pathogenesis of renal defects. Moreover, in Cognard et al., the authors compared kidney function and structure in total Bbs10 -/-versus a renal epithelial specific Bbs10 knockout mice, to dissect the effect of intrinsic versus systemic BBS inactivation. Total Bbs10 -/-mice recapitulated most of the clinical features of human BBS phenotype, including retinal degeneration, obesity, histological and functional renal impairment whereas the renal epithelial specific Bbs10 knockout mice did not exhibit any structural or functional renal abnormality, suggesting that systemic deletion of BBS10 is required to generate kidney dysfunction in mice [60] .
Conclusion
BBS is an emblematic ciliopathy; a systemic disorder associated with genetic mutations in 21 different genes coding for proteins that are primarily involved in the function of the PC/basal body complex. In the BBS, kidney disease is considered as one of the main cause of morbidity and mortality, however to date, little information is available on the exact pathogenic mechanism. Understanding the molecular basis underlying kidney disease and identifying all possible confounding factors influencing the onset and/or the severity of renal dysfunction are the prerequisites in developing novel and effective therapeutic strategies to prevent or slow kidney disease progression in the BBS.
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